These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8466882)

  • 1. Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men.
    Yang XC; Jing TY; Resnick LM; Phillips GB
    Arterioscler Thromb; 1993 Apr; 13(4):467-71. PubMed ID: 8466882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension.
    Phillips GB; Jing TY; Resnick LM; Barbagallo M; Laragh JH; Sealey JE
    J Hypertens; 1993 Jul; 11(7):699-702. PubMed ID: 8228187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, hemostatic factors, and hormone interactions in pre- and perimenopausal women: SWAN.
    Sowers M; Derby C; Jannausch ML; Torrens JI; Pasternak R
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4904-10. PubMed ID: 14557472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women.
    Meilahn EN; Cauley JA; Tracy RP; Macy EO; Gutai JP; Kuller LH
    Am J Epidemiol; 1996 Jan; 143(2):159-66. PubMed ID: 8546117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity.
    Phillips GB
    Metabolism; 1993 Jan; 42(1):116-20. PubMed ID: 8446038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men.
    Van Pottelbergh I; Braeckman L; De Bacquer D; De Backer G; Kaufman JM
    Atherosclerosis; 2003 Jan; 166(1):95-102. PubMed ID: 12482555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic variability of hemostatic and fibrinolytic factors in young women.
    Giardina EG; Chen HJ; Sciacca RR; Rabbani LE
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6179-84. PubMed ID: 15579775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
    Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic risk factors of coronary artery disease in the Chinese.
    Ho CH; Wang SP; Jap TS
    Int J Cardiol; 1995 Aug; 51(1):79-84. PubMed ID: 8522401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary risk factors and plasma sex hormones.
    Lindholm J; Winkel P; Brodthagen U; Gyntelberg F
    Am J Med; 1982 Nov; 73(5):648-51. PubMed ID: 6890309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
    Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.
    Smith AM; English KM; Malkin CJ; Jones RD; Jones TH; Channer KS
    Eur J Endocrinol; 2005 Feb; 152(2):285-91. PubMed ID: 15745938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipoproteins, sex hormones and sex hormone binding globulin in middle-aged men of different physical fitness and risk of coronary heart disease.
    Hämäläinen E; Tikkanen H; Härkönen M; Näveri H; Adlercreutz H
    Atherosclerosis; 1987 Oct; 67(2-3):155-62. PubMed ID: 3675710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort.
    Leifke E; Gorenoi V; Wichers C; Von Zur Mühlen A; Von Büren E; Brabant G
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):689-95. PubMed ID: 11155090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous sex hormone levels and coronary heart disease risk in postmenopausal women: A meta-analysis of prospective studies.
    Wang H; Li Y; Wang X; Bu J; Yan G; Lou D
    Eur J Prev Cardiol; 2017 Apr; 24(6):600-611. PubMed ID: 28326829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with a GnRH analogue: effects on hemostatic risk factors for thrombo-embolic disease.
    Lindoff C; Petersson F; Samsioe G; Astedt B
    Int J Fertil Menopausal Stud; 1994; 39(3):133-9. PubMed ID: 7920748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Serum Sex Hormones with Hemostatic Factors in Women On and Off Hormone Therapy: The Multiethnic Study of Atherosclerosis.
    Williams MS; Cushman M; Ouyang P; Heckbert SR; Kalyani RR; Vaidya D
    J Womens Health (Larchmt); 2016 Feb; 25(2):166-72. PubMed ID: 26700933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.